10 Mar 2015 Myriad RBM Launches New Immunoassay Services Based on the Ultrasensitive Simoa™ Platform March 10, 2015 Rules-Based Medicine Press Media Contact: Ron Rogers (801) 584-3065 rrogers@myriad.com Investor Contact: Scott Gleason (801) 584-1143 sgleason@myriad.com ...Read More
20 Jan 2015 Myriad RBM Joins Institut Pasteur in the Global Fight against Tuberculosis January 20, 2015 Rules-Based Medicine Press Media Contact: Ron Rogers (801) 584-3065 rrogers@myriad.com Investor Contact: Scott Gleason (801) 584-1143 sgleason@myriad.com ...Read More
20 Mar 2014 Institut Pasteur and Myriad RBM Publish Initial Results from Landmark Study of Immune Response March 20, 2014 Rules-Based Medicine Press Media Contact: Ron Rogers (801) 584-3065 rrogers@myriad.com Investor Contact: Scott Gleason (801) 584-1143 sgleason@myriad.com Institut Past...Read More
19 Jun 2013 DaVita Labs and Myriad RBM Announce Biomarker Research Collaboration June 19, 2013 Rules-Based Medicine Press DaVita Contact: Bianca Violante (303) 876-6614 bianca.violante@davita.com Investor Contact: Jim Gustafson (310) 536-2585 jim.gustafson@davita...Read More
10 Dec 2012 Myriad Announces Diabetes Collaboration with Sanofi – Press Release December 10, 2012 Rules-Based Medicine Press Myriad Contacts Investor Relations: Jim Evans, Chief Financial Officer (801) 584-1143 investors@myriad.com Myriad RBM: Chris Martin, Director o...Read More
25 Jul 2012 Bio-Rad and Myriad RBM Partner to Commercialize Multiplex Biomarker Kits for Life Science Research July 25, 2012 Rules-Based Medicine Press HERCULES, CA and AUSTIN, TX July 24, 2012 - Bio Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life scie...Read More
9 May 2012 Myriad RBM Announces the Launch of OncologyMAP® v. 2.0 May 9, 2012 Rules-Based Medicine Press New panel expands Myriad RBM's cancer-related drug and companion diagnostic discovery service offering. Salt Lake City, UT (PRWEB) May 09, 2012...Read More